作为急性肝衰竭的预后标志物,体重指数升高:从二十年的队列研究中得出结论
1Department of Medicine, All India Institute of Medical Sciences Bhubaneswar, Bhubaneswar 751019, Odisha, India. shreerath4a@gmail.com.
World journal of clinical cases
|December 11, 2025
概括
肥胖显著恶化了急性肝衰竭 (ALF) 患者的结果. 超重和肥胖的人面临死亡或肝移植的两倍风险,突出了针对性策略的必要性.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 代谢健康 代谢健康
- 临床预测 临床预测
背景情况:
- 全球肥胖患病率正在上升.
- 肥胖对急性肝衰竭 (ALF) 的预后影响在美国队列中未得到充分研究.
研究的目的:
- 评估和语境化身体质量指数 (BMI) 和ALF结果之间的关联.
- 评估超重和肥胖对ALF患者死亡率和肝移植的影响.
主要方法:
- 在二十年内对196名ALF患者进行了回顾性分析.
- 检查高BMI和ALF结局之间的关联,调整以考虑混因素.
主要成果:
- 超重和肥胖独立地使死亡或肝移植的风险增加了一倍.
- 升高的BMI与肝脏脑病和功能障碍的严重程度增加相关.
结论:
- 升高的BMI与ALF的不良结果有关.
- 未来的研究应该探索BMI以外的代谢健康标志物,以改善预后.
- 针对肥胖ALF患者需要有针对性的临床策略.
相关概念视频
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
169
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
169
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
200
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
200
Ultrasound II: Endoscopic Ultrasound and FibroScan
499
Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):
Endoscopic Ultrasound (EUS):
499
Diseases of the Liver and Gallbladder
1.8K
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
1.8K


